ANIX Anixa Biosciences Inc

$ANIX Excellent presentation by CEO Kumar this AM to Cantor Fitzgerald of Phase 1 Results.

$ANIX today announced that a patient in its ongoing Phase 1, dose-escalating, clinical trial evaluating its novel FSHR-targeted CAR-T therapy for recurrent ovarian cancer, exhibited stable disease 90 days after treatment. This represents the first such response in Anixa's CAR-T cell therapy trial. Correlative studies evaluating presence and durability of CAR positive cells are ongoing. The patient was treated in the fifth dose cohort and received a dose of 1×10⁷ CAR-positive cells per kilogram of body weight following lymphodepletion, representing the highest dose level evaluated to date in the study. To date, no dose-limiting toxicities have been observed in any patients.

$ANIX share price is reflecting considerable skepticism, but the behavior of its insiders doesn’t look like the behavior of people who share that pessimism. They’re buying meaningful amounts of stock with their OWN money after the delays, after the latest financial results, and around the current depressed valuation. That suggests they believe the market is undervaluing what ANIX has; not that they know the outcome of the trials, BUT, that they’re willing to put substantial personal capital behind their assessment of the risk/reward.

$ANIX the amount of shares purchased from executives over last year is insane. This has to mean something

$ANIX 🚨 ANIX INSIDER BUY Director Lewis H. Titterton Jr. just purchased 49,036 ANIX shares at $2.69/share — approximately $131,907. That brings his direct holdings to 1,046,003 shares.

$ANIX So let me get this straight, the executive team gets salaries well beyond what they deserve and then they keep buying shares at the dip to prop it up. I can only hope they know something we don't.

$ANIX i own enough of this.I wish they'd stop playing games, not buying, not selling every day.It's the same, sell off, run up after manipulation at its finest!

$ANIX On September 10, immediately after the 10-Q/LD Micro period, Kumar bought 8,000 shares total and Titterton bought 10,000, for roughly $49,350 of combined insider buying that day.

$ANIX This is interesting! A newly surfaced report says Amit Kumar purchased another 5,000 ANIX shares on September 10 at approximately $2.76 per share, about $13,800, bringing his direct holding to roughly 662,000 shares.

$ANIX If you won't listen, you'll have to feel the pain of your money losing its value. People have been getting ripped off here for nearly a decade. 🙈

I looked at the business behind $ANIX (Anixa Biosciences Inc) for you. Based on financial data and reported results. #ANIX

I looked at the business behind $ANIX (Anixa Biosciences Inc) for you. Based on financial data and reported results. #ANIX